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OBJECTIVE: To determine if Staphylococcus aureus and 
Staphylococcus epidermidis, etiologic bacterial agents to late 
prosthetic joint infections (LPJI), are more prevalent in the 
oral flora of older individuals with rheumatoid arthritis (RA) 
than in an age and gender-matched nonarthritic control 
population (NA). 
DESIGN: Cultures were obtained from the nares, orophar- 
ynx, saliva, tongue, and gingival crevice, and the results were 
compared between older patients with RA and controls. 
SETTING: University of Michigan Medical Center, Ann 
Arbor, VA Medical Center, and University of Michigan 
School of Dentistry. 
PARTICIPANTS: A total of 11 1 community-dwelling sub- 
jects with a diagnosis of RA and 83 gender-matched control 
subjects. 
MEASUREMENTS: Colistin nalidixic acid agar plates with 
5% sheep's blood were inoculated and incubated. Isolates 
were speciated using the API Staph Trac@ micro method and 
catalase and coagulase tests. 
MAIN RESULTS: Individuals with RA had a higher preva- 
lence of S. aureus isolated from the oral cavity. However, 
only the oropharynx and tongue revealed higher rates; all 
other sites were insignificant. The presence of oral S. aureus 
was associated with xerostomia. Staphylococcus epidermidis 
was not detected from any of the oral sites sampled. Sixty- 
two percent (10/16) of the S. aureus isolates from the RA 
subjects were resistant to penicillin and ampicillin, whereas 
none were resistant to a cephalosporin. 
CONCLUSIONS: These findings suggest that rheumatoid 
arthritis may be a risk factor for LPJI in older prosthetic joint 
patients undergoing invasive dental procedures in the poste- 
rior oral cavity. This increased risk is caused, in part, by a 
higher prevalence of S.  aureus in the posterior oral cavity. The 
prevalence and the antibiotic resistance of S. aureus must be 
considered when determining the need for chemoprophy- 
laxis. J Am Gerian SOC 45590-593, 1997. 
ontroversy exists regarding the management of dental C patients with prosthetic joints. Late prosthetic joint in- 
fections (LPJI) can cause serious illness in older patients.'-4 
Theoretically, older patients are at risk for costly, morbid 
LPJIs following a bacteremia associated with dental therapy. 
Nevertheless, because of the risk of the side effects of antibi- 
otics, as well as the cost-effectiveness of antibiotic prophy- 
laxis for all dental patients with prosthetic joints, chemopro- 
phylaxis has been challenged.'*2 Rheumatoid arthritis (RA) 
has been suggested as a risk factor, either becuse of its 
demonstrated decreased granulocyte migration or the immu- 
nosuppressive agents used in its treatment.4-6 In addition, 
strong evidence exists that corticosteroids, used in the man- 
agement of arthritic patients, alter the microbial oral flora.' 
The implicated bacteria in LPJIs are mainly Staphylococ- 
cus epidermidis and Staphylococcus aurus, uncommon oral 
 pathogen^.^.^ However, prosthetic joint patients with RA and 
a long history of immunosuppressive therapy may have oral 
flora quite unlike a nonarthritic population. Specifically, S. 
epidermidis and S.  aureus may be present more frequently in 
the oral cavity, which could increase the risk for LPJI. Recent 
evidence also suggests that S. aureus may be present in the 
subgingival flora of patients with periodontal disease." 
The purpose of this study was to determine (1) if the 
bacteria most often implicated in LPJIs were present in the 
oral cavity of an older population, and (2) if these bacteria 
were more prevalent in a population with RA than in an age 
and gender-matched nonarthritic (NA) control group. Addi- 
tionally, this study sought the detection rates of S. aureus and 
S.  epidermidis among several oral sites. The hypothesis that S. 
aureus and S.  epidermidis are more prevalent in a rheumatoid 
arthritic population is based on the observation that immu- 
nosuppressive therapy has been shown to alter the oral flora. 
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the University of Michigan Geriatric Center Human Subjects 
Core. Each patient provided oral and written consent. 
Inclusion criteria for the experimental population in- 
cluded a diagnosis of rheumatoid arthritis by a rheumatolo- 
gist and long-term (greater than 6 months) corticosteroid 
therapy. Subjects with a history of antibiotic therapy (within 
6 weeks), and diabetes were excluded. The control group 
(NA) was selected based on age (within 2.5 years) and gender 
match to the experimental group. Potential control subjects 
were excluded if they had any major illnesses such as a history 
of arthritis, diabetes, antibiotic therapy (within 6 weeks) or 
immunosuppressive treatment. Twenty-five of 225 subjects 
declined participation in the study. As shown in Table 1, 
there were no significant differences in age or gender between 
the experimental (RA) and control (NA) groups. 
Each subject completed a health questionnaire that in- 
vestigated their history of major illnesses, prosthetic joints, 
persistent dry mouth, use of tobacco products, antibiotics 
within the recent past (within 6 weeks), and current medica- 
tions. All health questionnaires were reviewed by investiga- 
tors B.P. and G.A., and histories of xerostomia were clinically 
verified. 
Microbial Sampling 
Microbial samples were obtained from the following sites 
during the months of June, July, and August: 
1 .  
2. 
3. 
Unstimulated saliva was collected in sterile cups from 
83 experimental and 83 control subjects, and 0.1 mL 
was streaked onto Colistin nalidixic acid (CNA) 5 %  
sheep’s blood agar with a sterile disposable loop. Sub- 
jects were instructed about expectoration to avoid con- 
tamination of specimen during collection. Samples were 
collected at least 1 hour after drinking or eating. Thirty- 
four RA patients were unable to produce a salivary 
sample because of hyposalivation. 
A sterile cotton-tipped applicator was placed and ro- 
tated on the posterior wall of the oropharynx of all RA 
and NA subjects. Thirteen experimental subjects were 
unable to provide a sample because of stimulation of the 
“gag reflex.” 
Unattached subgingival flora was obtained as described 
by Slots.’ Using a sterile forceps, a fine absorbent paper 
point was inserted to the depth of the gingival sulcus of 
a tooth. The paper point samples were obtained after 
removal of supragingival plaque with sterile gauze. 
Tooth selection was based on the following selection 
sequence: maxillary incisors, mandibular incisors, max- 
Table 1. Description of the Population Studied 
Rheumatoid Non-rheumatoid 
Arthritis Arthritis 
n = 1 1 1  n = 83 
Male 74 50 
Female 37 33 
Ratio male:female* 2.00 1.52 
Age (years, 58.7 2 11.64 55.9 2 12.91 
mean ? S.D.)** 
‘ Chi-square, no significant difference ( P  value = .3S6). 
* *  One sample student’s t test, n o  significant difference ( P  value = ,975). 
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illary molars, mandibular molars, maxillary cuspids, 
mandibular cuspids, and maxillary/mandibular pre- 
molars. A maximum of two subgingival sites was sam- 
pled on each subject. 
Attached subgingival flora was obtained by inserting a 
curette to the depth of the gingival sulcus and withdrawing 
the instrument slowly with the cutting edge of the instrument 
against the root or tooth surface. The same selection sequence 
as described above was used. A maximum of two subgingival 
sites was sampled on each subject. 
4. Using a sterile cotton tip applicator, samples were 
obtained from the posterior one-third of the tongue of 
32 randomly selected RA subjects and 83 NA sub- 
jects. Before sampling, the dorsal surface of the 
tongue was blotted lightly with sterile gauze to re- 
move any remaining saliva. Insufficient funds pre- 
cluded sampling of all 11 1 RA subjects. Since previ- 
ous investigators have concluded that a saliva sample 
is reflective of the palatel, buccal mucosa, and tongue, 
it was decided by the investigators to limit the tongue 
sampling to this randomly selected subgroup.12 
All specimens were streaked on to CNA sheep’s blood 
agar for isolation and incubated at 37°C for 24 hours. Staph- 
ylococcal identification was based on colony morphology, 
Gram-stain characteristics, catalase reaction, coagulase test, 
latex agglutination and API Staph TracO identification. 
Data Analysis 
The chi-square analysis was used to assess differences in 
the prevalence of staphylococci among the subject groups 
and gender differences between experimental and control 
groups. A value of P < .05 was chosen for statistical signifi- 
cance. A student’s t test was employed to assess differences in 
mean ages of the RA and NA groups. Again, P < .05 was 
required for statistical significance. 
RESULTS 
A description of the study population is provided in 
Table 1. Although there are differences in the mean ages 
(RA = 58.7 years vs NA = 55.9 years) and the ratio of males 
to females (RA = 2.00 vs NA = 1.52) between the experi- 
mental and control populations, the differences are slight and 
not statistically significant. 
The prevalence of S .  aureus at the oral sites sampled is 
displayed in Table 2. Please note some subjects exhibited 
more than one positive site in the oral cavity. Thus, the 
experimental subjects grew S.  aureus from 26 oral sites. Of 
Table 2. The Prevalence of Oral Staphylococcus aureus 
Experimental Control 
Sample Site (RA)* n = 1 1  1 (NA)t n = 83 P Value 
Oro-pharynx 13/104 (1 2.5%) 3/83 (3.6%) P = .031 
Saliva 7/83 (8.4%) 3/83 (3.6%) P = .192 
Tongue 4/32 (12.5%) 1/83 (1.2%) P = .008 
Gingival sulcus 2/82 (2.4%) 2/83 (2.4%) P = .990 
Total subjects$ 1611 1 1  (14.4%) 3/83 (3.6%) P = .012 
* RA = Rheumatoid arthritis. 
t NA = No arthritis. 
$ Some subjects grew out S. aureus at more than one site. 
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the 194 experimental and control subjects examined, only 19 
subjects (16 RA and 3 NA) had S. uureus cultured from the 
oral sites sampled. The higher prevalence of S. uureus in the 
RA population, 14.4% (16/111), compared with the NA 
population, 3.6% (3/83), is statistically significant (Table 3). 
Statistically significant differences (P < .05) between RA 
and NA patients were found in the prevalence of S. uureus in 
the oropharynx (RA = 131104 vs NA = 3/83) and the tongue 
(4/32 vs 1/83). The remaining oral sites revealed either no 
growth or statistically insignificant differences in prevalence 
of S. uureus. However, it should be noted that the prevalence 
of S. uureus in the saliva of the RA population was nearly 
twice that of NA subjects. 
Table 3 illustrates the distribution of S. uureus positive 
sites in the RA population studied. Of the 111 subjects 
sampled, 16 (14.41 %) revealed the presence of S. aureus in at  
least one of the oral sites. Thirteen of the 16 RA subjects had 
S. uureus cultured from their oropharynx. Additionally, all 
but one RA patient (#36) with S. aureus detected in the saliva 
also had S.  aureus cultured from the oropharynx. These 
findings suggest that the posterior oropharynx, not the gingi- 
val sulcus or tongue, may be the source of oral S. uureus. 
Table 4 displays the association between oral S. uureus 
and xerostomia. There is strong evidence ( P  value < .05) that 
xerostomia and the prevalence of S. uureus are associated. 
Staphylococcus epidermidis was not detected in any of 
the oral sites sampled in the study. 
The results of the antibiotic sensitivity of oral S. uureus 
are seen in Table 5. A random selection of 15 cultures of S. 
aureus from all strains of S .  uureus collected during the study 
was used for this analysis. Not unexpectedly, a high rate of 
resistance to penicillin (69%) and ampicillin (73%) was 
encountered. Further, no isolates were resistant to cefaclor, 
which simply means that none of these isolates were methi- 
Table 3. Distribution of S. aureus Positive Sites in Rheumatoid 
Arthritis Subjects 
Culture Sites 
Age Gingival 
Subject (yrs) Gender Oropharynx Saliva Tongue Sulcus 
001 
003 
01 4 
01 7 
01 8 
01 9 
023 
036 
043 
064 
078 
079 
081 
083 
085 
090 
71 M 
48 M 
62 M 
64 M 
40 M 
61 M 
57 M 
62 F 
44 M 
74 M 
36 M 
74 M 
69 M 
70 F 
63 M 
73 M 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
0 
+ 
+ 
+ 
+ 
0 
+ 
+ 
0 
Average: 60.5 Totals: 13 
0 0 
0 0 
+ 0 
+ 0 
0 0 
+ 0 
0 0 
+ 0 
+ 0 
0 0 
0 0 
+ 0 
0 + 
0 + 
+ + 
0 + 
7 4 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
+ 
+ 
0 
0 
0 
2 
Table 4. Xerostomia and Prevalence of Oral Staphylococcus - -  
aureus in Rheumatoid Arthritis Subjects 
Xerostomia No Xerostomia 
(+) Culture for S. aureus 8 8 
(-) Culture for S. aureus 15 80 
Total (n = 111) 23 88 
Chi-square P value = ,002. 
Table 5. The Antibiotic Sensitivity of Oral S. aureus 
Zones of Inhibition 
Antibiotic Resistant Intermediate Susceptible 
Penicillin 
Ampicillin 
Amoxicillin with 
Erythromycin 
Doxycycline 
Clindamycin 
Vancomycin 
Gentam ycin 
CefacloP (a 
clavulonic acid 
cephalosporin) 
~- 
0 
0 
0 
7 
0 
0 
0 
0 
2 
6 
6 
15 
7 
15 
15 
15 
15 
13 
cillin-resistant. One-half of the S. uureus isolates revealed 
intermediate or lesser zones of inhibition to erythromycin. 
DISCUSSION 
Before conclusions are reached, the limitations of this 
clinical study need to be recognized and their impact fully 
appreciated. Because the purpose of this study was to estab- 
lish the prevalence of S. aureus in rheumatoid arthritis and in 
an age-gender matched control, we did not attempt to deter- 
mine the relative quantity of S. aureus. Quantitative studies 
would be significant since previous investigations have shown 
a direct correlation between the level of bacteremia and 
subsequent LPJIs.'~ Further, the incidence of S. uureus and S.  
epidermidis was not established in this study. One assumes 
that the presence of these bacteria would change, and this 
change might be attributed to the rheumatoid arthritis and/or 
the immunosuppressive agents used to control it. Six experi- 
mental patients underwent repeat sampling 6 months after 
the initial oral sampling. Two subjects went from positive to 
negative cultures of S. aureus, two switched from negative to 
positive, and two remained unchanged. In these two subjects, 
one does not know if this condition represents loss and 
reacquisition of an organism or persistence of the same or- 
ganism. Although the question of oral microbial flora 
changes over time needs to be addressed in a larger study, one 
can still reach conclusions about the prevalence of these oral 
microbes in the present study. 
One of the issues central to the controversy about man- 
agement of dental patients with prosthetic joints is whether 
the bacteria implicated as the causative microbes of LPJI are 
present in the oral cavity of these patients. The findings from 
this study suggests that adult patients with rheumatoid ar- 
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thritis have a significantly higher prevalence of oral S.  aureus, 
particularly in the posterior areas (oropharynx and posterior 
tongue) than an age and gender-matched control population 
(Table 3 ) .  Although the RA population demonstrated a prev- 
alence of S. aureus nearly four times higher than the NA 
control group (14.4% vs 3.6%), the oral sites on and around 
teeth revealed no  differences. The prevalence of S. aureus in 
the RA population compares well to reported detection rates 
(18%) of Kondell in a “chronically ill and aged” popula- 
tion.14 
The detection pattern (Table 3 )  seen in the rheumatoid 
arthritis population suggests that the source of the oral S. 
aureus may be the oropharynx. The internal nares are prob- 
ably the main reservoir of S. aureus, and colonization of the 
mucosal surfaces proceeds into the oropharynx and other 
mucosal surfaces of the posterior oral cavity. These results 
are supported by previous reports, which conclude that S. 
aureus carriage in the nose ranges from 0 to 50% in healthy 
individuals whereas 41 to 70% of hospital patients were 
positive for S. aureus. l 4  
The findings from this study can be interpreted in several 
ways. First, the results suggest that adult rheumatoid arthritis 
patients have a significantly higher prevalence of oral S. 
aureus than an age and gender-matched control population 
(Table 2). Second, the data support the view that S. aureus 
colonizes from the nares to the orophaynx to the tongue, but 
less to the saliva or the gingival sulcus. Therefore, although 
RA patients with prosthetic joints may have a higher preva- 
lence of S. aureus, the location of oral S. aureus is such that 
dental procedures involving the teeth and gingival crevice 
may not predispose an individual to a bacteremia with S. 
aureus. The exception would be invasive dental procedures 
that manipulate the posterior oral cavity or oropharynx. 
Another commonly implicated etiological bacteria for 
LPJIs, S. epidermidis, was not detected in any of the oral sites 
of the subjects in this study. Consequently, older prosthetic 
joint patients, with or without rheumatoid arthritis, do not 
appear to be at a greater risk for LPJl from oral S. epidemidis. 
Although the detection of S. aureus and/or S.  epidermidis 
in a bacteremia of oral origin is rare, it is not unexpected 
when we consider the population used in previous studies,’.’ 
which is why this investigation was undertaken. From the 
results of this study, one could hypothesize that S. aureus 
would be more prevalent in an older, rheumatoid arthritis 
population with complaints of xerostomia than in a generally 
younger, healthy population that was the basis of previous 
bacteremic studies. 
Not surprisingly, the S. aureus isolated from the study 
population had a high rate of resistance to penicillin (69%) 
and ampicillin (73%), whereas no isolates were resistant to a 
cephalosporin (Table 5 ) .  Additionally, erythromycin was 
only moderately effective in inhibiting the growth of S. au- 
reus. Consequently, when determining the need for chemo- 
prophylaxis before dental procedures, the high rate of resis- 
tance of S. aureus must be considered. 
The question of the reasons for the higher prevalence of 
S. aureus in the oral cavity of older rheumatoid arthritis 
subjects remains. There is evidence that this higher preva- 
lence is attributable to the disease itself, as well as to the 
immunnosuppression these patients may be experiencing 
through drug therapy.8 A common complication of rheuma- 
toid arthritis is the sicca complex, which includes a decreased 
salivary flow resulting in xerostomia. Potentially this compli- 
cation results in a altered milieu, including decreased immun- 
noglobins from the saliva itself, leading to an altered oral 
flora. Although this study did not attempt to quantify the 
degree to which a decreased salivary flow affects the coloni- 
zation of the oral cavity with staphylococcus, there is strong 
evidence (Table 4) that an association does exist between 
xerostomia and oral S. aureus. Further quantitative studies 
are needed to establish whether a decreased salivary flow 
enhances or results in oral colonization with S.  aureus. 
The results of this study show that patients with RA are 
more likely than controls to carry S. aureus. Additional 
studies investigating the prevalence of S. aureus in a bactere- 
mia of oral origin are needed to determine if this older 
rheumatoid arthritis population is at an increased risk of 
LPJI. Presumably this increased risk would be caused by a 
higher prevalence of oral S. aureus, a bacteria often impli- 
cated as the cause of LPJI, on the oro-pharynx and posterior 
tongue. Any chemoprophylaxis regimen during dental treat- 
ment should take into consideration the high rate of resis- 
tance of S. aureus to penicillin, ampicillin, and, possibly, 
erythromycin. A prudent approach to all prosthetic joint 
patients seeking dental care should include a thorough his- 
tory to establish if the patient has any risk factors for LPJI. 
Following this investigation, if  one concludes that chemopro- 
phylaxis is in the patients best interest, the choice of antimi- 
crobials should be driven by the bacterial species one is 
attempting to diminish. 
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